Good evening :)
Place Order
Add to Watchlist

Dr Lalchandani Labs Ltd

DLCL Share Price

14.054.93% (+0.66)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹5 cr, stock is ranked 4,747

Stock is 6.42x as volatile as Nifty

DLCL Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹5 cr, stock is ranked 4,747

Stock is 6.42x as volatile as Nifty

DLCL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
0.61
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.256.500.86%

DLCL Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

DLCL Company Profile

Dr Lalchandani Labs is a provider of diagnostic and related healthcare tests and services.

DLCL Similar Stocks (Peers)

Compare with peers 
PE Ratio
103.79
1Y Return
39.69%
Buy Reco %
75.00
PE Ratio
68.17
1Y Return
15.51%
Buy Reco %
86.21
PE Ratio
72.05
1Y Return
66.69%
Buy Reco %
100.00
PE Ratio
44.72
1Y Return
46.86%
Buy Reco %
77.78
PE Ratio
66.79
1Y Return
6.64%
Buy Reco %
71.43
Compare with Peers

DLCL Forecasts

DLCL Forecast

Price

Revenue

Earnings

DLCL

Income

Balance Sheet

Cash Flow

DLCL Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 3.44%, vs industry avg of 10.01%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.01%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 3.91%, vs industry avg of 42.91%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue4.612.825.276.109.7811.285.046.244.46
Raw Materialssubtract3.370.590.611.153.612.981.212.063.41
Power & Fuel Costsubtract0.070.110.110.110.160.110.11
Employee Costsubtract0.300.670.570.421.111.110.72
Selling & Administrative Expensessubtract0.722.222.292.673.661.781.24
Operating & Other expensessubtract0.490.460.720.730.900.740.48
Depreciation/Amortizationsubtract0.170.130.350.420.520.590.660.620.56
Interest & Other Itemssubtract0.360.160.140.180.350.600.990.380.09
Taxes & Other Itemssubtract0.220.090.190.190.360.360.000.00-0.01
EPS35.470.921.431.082.332.12-3.601.450.96
DPS0.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.00

DLCL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

DLCL Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Dr Lalchandani Labs Ltd14.150.61
Max Healthcare Institute Ltd103.7913.280.13%
Apollo Hospitals Enterprise Ltd68.1713.460.41%
Fortis Healthcare Ltd72.056.520.14%

DLCL Stock Price Comparison

Compare DLCL with any stock or ETF
Compare DLCL with any stock or ETF
DLCL
Loading...

DLCL Shareholdings

DLCL Promoter Holdings Trend

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 8.86%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

DLCL Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

DLCL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding48.32%0.00%0.00%0.00%51.68%

Sep 2023

Mar 2024

Sep 2024

Mar 2025

DLCL Shareholding History

SepMarSepMarSepMar0.00%0.00%0.00%0.00%0.00%0.00%

DLCL Insider Trades & Bulk Stock Deals

Loading...

smallcases containing DLCL stock

Looks like this stock is not in any smallcase yet.

DLCL Events

DLCL Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

DLCL has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

DLCL Dividends

Hmm, looks like data is unavailable here. Please come back after some time

DLCL Stock News & Opinions

Corporate
Dr Lalchandani Labs to declare Quarterly Result

Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 1 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Dr Lalchandani Labs to announce Quarterly Result

Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 14 October 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Dr Lalchandani Labs to conduct AGM

Dr Lalchandani Labs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Dr Lalchandani Labs to convene AGM

Dr Lalchandani Labs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live

Thyrocare, Vijaya, other diagnostics shares jump up to 7% amid Covid scar

2 years agoBusiness Today

Dr Lalchandani Labs receive approval to be listed as COVID-19 Vaccination Centre

4 years agoIndia Infoline

Frequently asked questions

  1. What is the share price of Dr Lalchandani Labs Ltd (DLCL) today?

    The share price of DLCL as on 5th June 2025 is ₹14.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Dr Lalchandani Labs Ltd (DLCL) share?

    The past returns of Dr Lalchandani Labs Ltd (DLCL) share are
    • Past 1 week: 15.53%
    • Past 1 month: 21.07%
    • Past 3 months: -0.81%
    • Past 6 months: -23.44%
    • Past 1 year: -40.04%
    • Past 3 years: -48.30%
    • Past 5 years: 39.48%

  3. What are the peers or stocks similar to Dr Lalchandani Labs Ltd (DLCL)?
  4. What is the market cap of Dr Lalchandani Labs Ltd (DLCL) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Lalchandani Labs Ltd (DLCL) is ₹5.80 Cr as of 5th June 2025.

  5. What is the 52 week high and low of Dr Lalchandani Labs Ltd (DLCL) share?

    The 52-week high of Dr Lalchandani Labs Ltd (DLCL) is ₹28.90 and the 52-week low is ₹9.80.

  6. What is the PE and PB ratio of Dr Lalchandani Labs Ltd (DLCL) stock?

    The P/E (price-to-earnings) ratio of Dr Lalchandani Labs Ltd (DLCL) is 14.15. The P/B (price-to-book) ratio is 0.61.

  7. Which sector does Dr Lalchandani Labs Ltd (DLCL) belong to?

    Dr Lalchandani Labs Ltd (DLCL) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  8. How to buy Dr Lalchandani Labs Ltd (DLCL) shares?

    You can directly buy Dr Lalchandani Labs Ltd (DLCL) shares on Tickertape. Simply sign up, connect your demat account and place your order.